CLICK HERE to download the full program

 

Friday, September 21

 7:00 – 8:15 Meet the Professor Breakfast

---

 8:30 – 9:30 Plenary lecture

Bone-Kidney axis and vascular calcification

Chairmen: Keith Hruska & Sharon Moe

Cathy Shanahan, UK

---

9:30 – 10:00 Coffee Break & Exhibition

---

10:00 – 12:00 Phosphate and PTH - Basic science session

Chairmen: Robert Unwin & Heini Murer

Robert Unwin, UK
Phosphate homeostasis and the renal-gastrointestinal axis

Harald Jüppner, USA
Genetic disorders of renal phosphate transport

Mohammed S Razzaque, USA
New insights into phosphate toxicity

Serge L Ferrari, Switzerland
PTH and beta-arrestin dependent signalling

---

10:00 – 12:00 Vitamin D & calcimimetics - Clinical science session

Chairmen: Grahame Elder & David Goldsmith

Ravi Thadhani, USA
What should be the targets for levels of 25 (OH)D and 1,25 (OH)2D in CKD?

Elizabeth Shane, USA
Post transplant renal/bone/endocrine interactions

Seiji Fukumoto, Japan
New therapeutics for disorders of calcium and phosphate metabolism

John Cunningham, UK
Vitamin D sterols versus calcimimetics in the treatment of CKD-MBD

 

---

 

 

 12:15 – 13:15 Industry Lunch Symposium          

                                    

20 Years Later: Our Understanding of the Role of the Calcium-Sensing Receptor

Chronic Kidney Disease: Factors Influencing Cardiovascular Risk

---

13:15 – 14:45 Poster Sessions & Coffee Break

---

14:45 – 16: 45  Hyperparathyroidism and CKD - Translational session

Chairmen: Justin Silver & Mohammed S Razzaque

Adriana Dusso, Spain
Molecular basis of parathyroid hyperplasia

Justin Silver, Israel
Mechanisms of the increased FGF23 in sHPT

Pierre D'Amour, Canada
Biological importance of PTH fragments

Ewa Lewin, Denmark
Parathyroids and klotho

---

16:45 – 17: 15 Coffee Break & Exhibition

---

17:15 – 18:15 Plenary lecture

Chairmen: Jürgen Floege & Harold Jüppner

Renal and intestinal divalent ion transport
Rene Bindels, The Netherlands 

---

 

18: 15 – 20:00 CKD - MBD: New approaches and results

Chairman: Tilman Drüeke & Masafumi Fukagawa

Masafumi Fukagawa, Japan
Gene therapy for sHPT

Ravi Thadhani, USA
The Phosphate Normalization Trial in CKD patients not yet on dialysis

Oral presentations from the best poster submissions